These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1520538)

  • 1. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
    Aoki-Sei S; Yarchoan R; Kageyama S; Hoekzema DT; Pluda JM; Wyvill KM; Broder S; Mitsuya H
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1263-70. PubMed ID: 1520538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription.
    Kojima E; Shirasaka T; Anderson B; Chokekijchai S; Sei S; Yarchoan R; Mitsuya H
    AIDS; 1993 Nov; 7 Suppl 2():S101-5. PubMed ID: 8161438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
    Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
    AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and detection of a single molecule of human immunodeficiency virus RNA.
    Nakamura S; Katamine S; Yamamoto T; Foung SK; Kurata T; Hirabayashi Y; Shimada K; Hino S; Miyamoto T
    Virus Genes; 1993 Dec; 7(4):325-38. PubMed ID: 8122393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
    Yerly S; Kaiser L; Baumberger C; Hirschel B; Perrin LH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):358-64. PubMed ID: 7882100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.
    Bush CE; Donovan RM; Smereck SM; Strang D; Markowitz N; Saravolatz LD
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):183-7. PubMed ID: 8096146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma viraemia as a marker of viral replication in HIV-infected individuals.
    Escaich S; Ritter J; Rougier P; Lepot D; Lamelin JP; Sepetjan M; Trepo C
    AIDS; 1991 Oct; 5(10):1189-94. PubMed ID: 1723881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 plasma viraemia quantification: a non-culture measurement needed for therapeutic trials.
    Semple MG; Kaye S; Loveday C; Tedder RS
    J Virol Methods; 1993 Feb; 41(2):167-79. PubMed ID: 8496293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
    Mole L; Margolis D; Carroll R; Todd J; Holodniy M
    J Clin Microbiol; 1994 Sep; 32(9):2212-5. PubMed ID: 7814549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI).
    Aoki S; Yarchoan R; Thomas RV; Pluda JM; Marczyk K; Broder S; Mitsuya H
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1331-9. PubMed ID: 2127682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
    Ved Brat SS; Shepherd LP; Boulberhane A; Pierce PF; Hellman KB
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1271-81. PubMed ID: 1520539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
    New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV-1 proviral DNA sequences in the saliva of patients with HIV infection].
    Piazza M; Chirianni A; Liuzzi G; Tullio Cataldo P; Santoro G; Barsanti L; Batoni G; Ceccherini Nelli L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):475-81. PubMed ID: 1362355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.
    Schnittman SM; Greenhouse JJ; Lane HC; Pierce PF; Fauci AS
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):361-7. PubMed ID: 1676896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
    Semple M; Loveday C; Weller I; Tedder R
    J Med Virol; 1991 Sep; 35(1):38-45. PubMed ID: 1940882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
    Muñoz-Fernández MA; Navarro J; Montes MG; Cosín J; Zabay JM; Fernández-Cruz E
    J Clin Microbiol; 1996 Feb; 34(2):404-8. PubMed ID: 8789024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring viral load in the clinical setting.
    Harrigan R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S34-40. PubMed ID: 8595506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.